Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children.

Sandritter TL, Goldman JL, Habiger CJ, Daniel JF, Lowry J, Fischer RT.

Sci Rep. 2019 Dec 2;9(1):18090. doi: 10.1038/s41598-019-54075-4.

2.

Barriers to ideal outcomes after pediatric liver transplantation.

Ng VL, Mazariegos GV, Kelly B, Horslen S, McDiarmid SV, Magee JC, Loomes KM, Fischer RT, Sundaram SS, Lai JC, Te HS, Bucuvalas JC.

Pediatr Transplant. 2019 Sep;23(6):e13537. doi: 10.1111/petr.13537. Epub 2019 Jul 25.

PMID:
31343109
3.

Dehydrated Hereditary Stomatocytosis Presenting as Severe Perinatal Ascites and Cholestasis.

Halma J, Petrikin J, Daniel JF, Fischer RT.

J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):e52-e53. doi: 10.1097/MPG.0000000000002077. No abstract available.

PMID:
29952828
4.

The impact of thromboelastography on resuscitation in pediatric liver transplantation.

Sujka J, Gonzalez KW, Curiel KL, Daniel J, Fischer RT, Andrews WS, Wicklund BM, Hendrickson RJ.

Pediatr Transplant. 2018 Jun;22(4):e13176. doi: 10.1111/petr.13176. Epub 2018 Mar 26.

PMID:
29577520
5.

Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection.

Mathews LR, Lott JM, Isse K, Lesniak A, Landsittel D, Demetris AJ, Sun Y, Mercer DF, Webber SA, Zeevi A, Fischer RT, Feingold B, Turnquist HR.

Am J Transplant. 2016 Mar;16(3):938-50. doi: 10.1111/ajt.13542. Epub 2015 Dec 11.

6.

Epidemiology and Healthcare Resource Utilization Associated With Children With Short Bowel Syndrome in the United States.

Pant C, Sferra TJ, Fischer RT, Olyaee M, Gilroy R.

JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):878-883. doi: 10.1177/0148607115616079. Epub 2015 Oct 30.

PMID:
26518221
7.

Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings.

Willig LK, Petrikin JE, Smith LD, Saunders CJ, Thiffault I, Miller NA, Soden SE, Cakici JA, Herd SM, Twist G, Noll A, Creed M, Alba PM, Carpenter SL, Clements MA, Fischer RT, Hays JA, Kilbride H, McDonough RJ, Rosterman JL, Tsai SL, Zellmer L, Farrow EG, Kingsmore SF.

Lancet Respir Med. 2015 May;3(5):377-87. doi: 10.1016/S2213-2600(15)00139-3. Epub 2015 Apr 27.

8.

Intestinal transplantation in children with multiple intestinal atresias and immunodeficiency.

Fischer RT, Friend B, Talmon GA, Grant WJ, Quiros-Tejeira RE, Langnas AN, Coccia PF.

Pediatr Transplant. 2014 Mar;18(2):190-6. doi: 10.1111/petr.12211. Epub 2013 Dec 28.

PMID:
24373162
9.

Successful rehabilitation in pediatric ultrashort small bowel syndrome.

Infantino BJ, Mercer DF, Hobson BD, Fischer RT, Gerhardt BK, Grant WJ, Langnas AN, Quiros-Tejeira RE.

J Pediatr. 2013 Nov;163(5):1361-6. doi: 10.1016/j.jpeds.2013.05.062. Epub 2013 Jul 15.

PMID:
23866718
10.

Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor.

Acquazzino MA, Fischer RT, Langnas A, Coulter DW.

Pediatr Transplant. 2013 Aug;17(5):466-71. doi: 10.1111/petr.12101. Epub 2013 Jun 3.

PMID:
23730873
11.

Sequential histologic changes in the healing process in small bowel allografts treated for acute cellular rejection.

Liu L, Fischer RT, Xu L, Talmon GA.

Transplant Proc. 2013 Mar;45(2):643-8. doi: 10.1016/j.transproceed.2012.05.072. Epub 2012 Sep 12.

PMID:
23267814
12.

Hepatic fibrosis persists and progresses despite biochemical improvement in children treated with intravenous fish oil emulsion.

Mercer DF, Hobson BD, Fischer RT, Talmon GA, Perry DA, Gerhardt BK, Grant WJ, Botha JF, Langnas AN, Quiros-Tejeira RE.

J Pediatr Gastroenterol Nutr. 2013 Apr;56(4):364-9. doi: 10.1097/MPG.0b013e31827e208c.

PMID:
23201707
13.

Rapamycin-conditioned, alloantigen-pulsed myeloid dendritic cells present donor MHC class I/peptide via the semi-direct pathway and inhibit survival of antigen-specific CD8(+) T cells in vitro and in vivo.

Fischer RT, Turnquist HR, Wang Z, Beer-Stolz D, Thomson AW.

Transpl Immunol. 2011 Jul;25(1):20-6. doi: 10.1016/j.trim.2011.05.001. Epub 2011 May 10.

14.

Prognostic scoring indices in Wilson disease: a case series and cautionary tale.

Fischer RT, Soltys KA, Squires RH Jr, Jaffe R, Mazariegos GV, Shneider BL.

J Pediatr Gastroenterol Nutr. 2011 Apr;52(4):466-9. doi: 10.1097/MPG.0b013e31820b0211.

PMID:
21415672
15.

Pharmacological modification of dendritic cells to promote their tolerogenicity in transplantation.

Turnquist HR, Fischer RT, Thomson AW.

Methods Mol Biol. 2010;595:135-48. doi: 10.1007/978-1-60761-421-0_8.

PMID:
19941109
16.
17.

IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells.

Ettinger R, Sims GP, Robbins R, Withers D, Fischer RT, Grammer AC, Kuchen S, Lipsky PE.

J Immunol. 2007 Mar 1;178(5):2872-82.

18.

T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue.

Withers DR, Fiorini C, Fischer RT, Ettinger R, Lipsky PE, Grammer AC.

Blood. 2007 Jun 1;109(11):4856-64. Epub 2007 Feb 13.

19.

Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors.

Kenny JJ, Rezanka LJ, Lustig A, Fischer RT, Yoder J, Marshall S, Longo DL.

J Immunol. 2000 Apr 15;164(8):4111-9.

20.

Positive and negative selection of antigen-specific B cells in transgenic mice expressing variant forms of the V(H)1 (T15) heavy chain.

Kenny JJ, Derby EG, Yoder JA, Hill SA, Fischer RT, Tucker PW, Claflin JL, Longo DL.

Int Immunol. 2000 Jun;12(6):873-85.

PMID:
10837415
21.

Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse.

Mi QS, Zhou L, Schulze DH, Fischer RT, Lustig A, Rezanka LJ, Donovan DM, Longo DL, Kenny JJ.

Proc Natl Acad Sci U S A. 2000 May 23;97(11):6031-6.

22.
23.

Antiproliferative activity in vitro and in vivo of the spicamycin analogue KRN5500 with altered glycoprotein expression in vitro.

Burger AM, Kaur G, Hollingshead M, Fischer RT, Nagashima K, Malspeis L, Duncan KL, Sausville EA.

Clin Cancer Res. 1997 Mar;3(3):455-63.

24.

bcl-2 alters the antigen-driven selection of B cells in mukappa but not in mu-only Xid transgenic mice.

Kenny JJ, Fischer RT, Lustig A, Dintzis H, Katsumata M, Reed JC, Longo DL.

J Immunol. 1996 Aug 1;157(3):1054-61.

PMID:
8757609
25.
26.

Cholesterol quantitation by GLC: artifactual formation of short-chain steryl esters.

Klansek JJ, Yancey P, St Clair RW, Fischer RT, Johnson WJ, Glick JM.

J Lipid Res. 1995 Oct;36(10):2261-6.

27.

Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: II. Time-dependent enzyme inactivation by selected oxylanosterol analogs.

Trzaskos JM, Fischer RT, Ko SS, Magolda RL, Stam S, Johnson P, Gaylor JL.

Biochemistry. 1995 Aug 1;34(30):9677-81.

PMID:
7626637
28.

Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties.

Trzaskos JM, Ko SS, Magolda RL, Favata MF, Fischer RT, Stam SH, Johnson PR, Gaylor JL.

Biochemistry. 1995 Aug 1;34(30):9670-6.

PMID:
7626636
30.
31.

Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanism-based inhibitor of cholesterol biosynthesis.

Trzaskos JM, Magolda RL, Favata MF, Fischer RT, Johnson PR, Chen HW, Ko SS, Leonard DA, Gaylor JL.

J Biol Chem. 1993 Oct 25;268(30):22591-9.

32.

Selection of antigen-specific, idiotype-positive B cells in transgenic mice expressing a rearranged M167-mu heavy chain gene.

Kenny JJ, O'Connell C, Sieckmann DG, Fischer RT, Longo DL.

J Exp Med. 1991 Nov 1;174(5):1189-201.

33.

Lanosterol 14 alpha-methyl demethylase. Isolation and characterization of the third metabolically generated oxidative demethylation intermediate.

Fischer RT, Trzaskos JM, Magolda RL, Ko SS, Brosz CS, Larsen B.

J Biol Chem. 1991 Apr 5;266(10):6124-32. Erratum in: J Biol Chem 1991 Jul 25;266(21):14137.

34.

Generation of regulatory oxysterols: 26-hydroxylation of cholesterol by ovarian mitochondria.

Rennert H, Fischer RT, Alvarez JG, Trzaskos JM, Strauss JF 3rd.

Endocrinology. 1990 Aug;127(2):738-46.

PMID:
2373053
35.

Mechanistic studies of lanosterol 14 alpha-methyl demethylase: substrate requirements for the component reactions catalyzed by a single cytochrome P-450 isozyme.

Fischer RT, Stam SH, Johnson PR, Ko SS, Magolda RL, Gaylor JL, Trzaskos JM.

J Lipid Res. 1989 Oct;30(10):1621-32.

36.

A mammalian mutant cell lacking detectable lanosterol 14 alpha-methyl demethylase activity.

Chen HW, Leonard DA, Fischer RT, Trzaskos JM.

J Biol Chem. 1988 Jan 25;263(3):1248-54.

38.
40.

Fluorescence of delta 5,7,9(11),22-ergostatetraen-3 beta-ol in micelles, sterol carrier protein complexes, and plasma membranes.

Fischer RT, Cowlen MS, Dempsey ME, Schroeder F.

Biochemistry. 1985 Jun 18;24(13):3322-31.

PMID:
4027244
41.

Sterol and squalene carrier protein interactions with fluorescent delta 5,7,9(11)-cholestatrien-3 beta-ol.

Schroeder F, Dempsey ME, Fischer RT.

J Biol Chem. 1985 Mar 10;260(5):2904-11.

42.

Cytochrome P-450-dependent oxidation of lanosterol in cholesterol biosynthesis. Microsomal electron transport and C-32 demethylation.

Trzaskos JM, Bowen WD, Shafiee A, Fischer RT, Gaylor JL.

J Biol Chem. 1984 Nov 10;259(21):13402-12.

43.

delta 5,7,9(11)-Cholestatrien-3 beta-ol: a fluorescent cholesterol analogue.

Fischer RT, Stephenson FA, Shafiee A, Schroeder F.

Chem Phys Lipids. 1984 Nov;36(1):1-14.

PMID:
6518610

Supplemental Content

Loading ...
Support Center